Cjc-1295 Without Dac CAS NO.863288-34-0
- FOB Price: USD: 6.00-6.00 /Gram Get Latest Price
- Min.Order: 1 Gram
- Payment Terms: L/C,D/A,D/P,T/T,Other
- Available Specifications:
pharmaceutical Grade(1-10000000)Gram
- Product Details
Keywords
- Cjc-1295 Without Dac
- pharmaceutical peptide
- Peptide
Quick Details
- ProName: Cjc-1295 Without Dac
- CasNo: 863288-34-0
- Molecular Formula: C50H69N15O9
- Appearance: white apperance
- Application: Bodybuidling
- DeliveryTime: within 3 days after get your payment
- PackAge: Plastic Tube, Vial, Box
- Port: Qingdao Guangzhou
- ProductionCapacity: 10000000 Gram/Day
- Purity: 99%or above
- Storage: Keep it under seal in cool and dark pl...
- Transportation: DHL TNT FedEx EMS
- LimitNum: 1 Gram
Superiority
Details
This is Linda from Zhengzhou Filter Biotechnology Co.,Ltd.We are the professional supplier of peptide products in China over 10 years. we have Professional Lab to confirm the Quality and Serive for all clients in long-term run cooperation.
Our Company as a Pharmaceutical Raw Material Manufacturer specialize in R&D the New Drugs and Producing the Generic Medicine:
Amino Acids&Vitamins
Pharmaceutical Polypeptide,
Comestic Polypeptide,
Veterinary Peptide and
Pharmaceutical APIs.
Due to of the high quality and good service, They have been exported more than 30 countries.
Sincerely hope to have a chance to cooperate with you.
CJC-1295 DAC and CJC-1295 (also known as Modified GRF 1-29) are both Hormone Releasing Hormones (GHRH). Their action in the human body is identical but the difference between the two peptides are the span of the half-life. Modified GRF 1-29 and Sermorelin have a very short acting half-life of about 30 minutes, while CJC-1295 DAC has a half-life that can last up to approximately 8 days. Many a scientist have reported that the short half-life of Sermorelinand Modified GRF 1-29 is considered to be much more natural as they produce a short pulse of Human Hormone.
ConjuChem and The Development of CJC-1295 DAC
CJC-1295 DAC is a tetrasubstituted peptide analogue of Growth Hormone Releasing Hormones with D-Ala, Gln, Ala, and Leu substitutions at positions 2, 8, 15, and 27 respectively. A Canadian biotechnology companyConjuChem had invented CJC-1295. Clinical Research on CJC-1295 first began during the mid-2000s. The goal of the peptide, acting to raise like Ipamorelin, was to treat visceral fat deposits in obese AIDS patients because it is presumed that increased levels of exogenous increase fat loss, or lipolysis. In one study, results showed that the measured GH release in rats over a two hour period showed that CJC-1295 released twice as much GH as CJC-1293 DAC. This result makes it preferable for immediate effectiveness as a result of the longer peak. With the use of a Hormone Releasing Peptide (GHRP), such as Hormone Releasing Hexapeptide (GHRP-6)in conjuction with CJC-1295 DAC, a study has shown that the GHRP's create a Hormone pulse which helps the CJC-1295 work effectively. Clinical research's involving CJC-1295 have shown that it had been successful for most research subjects.
Peptide categories
Peptide Categories
Packaging&Shipping.Our Lab
Contact information
Linda 008618203638264